Davis Blaine
Chief Financial Officer
Davis Blaine has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jan 8, 2026.
On the most recent filing, Davis Blaine is listed as Chief Financial Officer at Cartesian Therapeutics, Inc. Inside the rolling window, Davis Blaine reported no open-market purchases and 1 open-market sale totaling $72K in RNAC.
Companies traded
Other insiders at RNAC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$72K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Davis Blaine made?
Davis Blaine has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Davis Blaine trade?
Davis Blaine has filed SEC Form 4 disclosures for 1 company, including RNAC.
When was Davis Blaine's most recent SEC Form 4 filing?
Davis Blaine's most recent SEC Form 4 filing on Tracefour is dated Jan 8, 2026.
What is Davis Blaine's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Davis Blaine is listed as Chief Financial Officer.
What is Davis Blaine's total buy and sell value in the current window?
Inside the rolling retention window, Davis Blaine bought $0 and sold $72K based on SEC Form 4 filings.
What was Davis Blaine's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,591 RNAC shares on 2026-01-06, worth $72K, per SEC Form 4 filings.